General MedicationsORALStandard
MELOXICAM
MELOXICAM
Standard Dose
7.5MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MELOXICAM is listed in Drugs@FDA under application 021530 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MELOXICAM Form and strength SUSPENSION;ORAL - 7.5MG/5ML Sponsor AVONDALE PHARMS Submission history Latest submission status date: 2024-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview MELOXICAM is listed in Drugs@FDA under application 021530 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MELOXICAM Form and strength SUSPENSION;ORAL - 7.5MG/5ML Sponsor AVONDALE PHARMS Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.